Potent P2Y12 inhibitor monotherapy without aspirin early after percutaneous coronary intervention: the NEO-MINDSET Platelet Function Substudy
Few data are available on platelet reactivity in patients exposed to potent P2Y12 inhibitor monotherapy without aspirin. This study was nested within the NEO-MINDSET trial, a multicenter, randomised trial evaluating potent P2Y12 inhibitor monotherapy early after percutaneous coronary intervention (PCI) for...